Fire + Hearing aids brings up an awful picture in our brains.
All ZeniPower mercury-free hearing aid batteries – low risk of batteries exploding during use or if depleted
Only batteries with best before dates of ’08-2018’ and ‘09-2018’ are affected.
If you purchased these batteries from NHS Supply Chain, their codes (NPC) are given below:
NPC (England only)
Manufacturer product code
R44 zinc air size 675 for cochlear implants
R44 zinc air size 675
R48 zinc air size 13
R41 zinc air size 312
R70 zinc air size 10
Since 13 January 2016, NHS Supply Chain has received new supplies of batteries, which do not exhibit this problem.
Problem / background
The problem is caused by excessive gassing, as the zinc electrode reacts with the electrolyte to generate hydrogen. The battery may expand and possibly explode on rare occasions. This issue affects all types of ZeniPower mercury-free batteries listed above.
If you are responsible for cascading these alerts in your organisation, these are our suggested distribution lists.
Trusts (NHS boards in Scotland)
CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:
Cochlear implant centres
ENT medical staff
ENT services, directors of
NHS England area teams
CAS liaison officers for onward distribution to all relevant staff including:
General practice managers
General practice nurses
Establishments registered with the Care Quality Commission (CQC) (England only)
Care homes providing nursing care (adults)
Care homes providing personal care (adults)
Domiciliary care providers
Further education colleges registered as care homes
Hospitals in the independent sector
Independent treatment centres
Private medical practitioners
Establishments registered with OFSTED
Educational establishments with beds for children
Residential special schools
Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: [email protected] and requesting this facility.
Send enquiries about this notice to MHRA, quoting reference number MDA/2016/003 or 2015/012/010/401/016.